1978
DOI: 10.1016/s0003-4975(10)62907-4
|View full text |Cite
|
Sign up to set email alerts
|

Saphenous Vein Bypass from the Aorta to the Anterior Interventricular Vein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

1980
1980
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(6 citation statements)
references
References 9 publications
0
6
0
Order By: Relevance
“…The reasons for this complication may be anatomical distortion due to myocardial scarring, intramyocardial course of intended artery, pericardial fibrosis, or previous coronary bypass surgery. Also, pericardial fat may disturb coronary exploration [ 3 , 4 ]. This iatrogenic CAVF may result in myocardial ischemia, infective endocarditis, severe systemic to pulmonary shunt, heart failure with high cardiac output, or fistula rupture [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…The reasons for this complication may be anatomical distortion due to myocardial scarring, intramyocardial course of intended artery, pericardial fibrosis, or previous coronary bypass surgery. Also, pericardial fat may disturb coronary exploration [ 3 , 4 ]. This iatrogenic CAVF may result in myocardial ischemia, infective endocarditis, severe systemic to pulmonary shunt, heart failure with high cardiac output, or fistula rupture [ 5 ].…”
Section: Discussionmentioning
confidence: 99%
“…The reasons of this complication may be anatomical distortion due to myocardial scarring, pericardial fibrosis, or previous coronary bypass operations. Also pericardial fat may disturb coronary exploration [ 5 7 ]. This iatrogenic coronary arteriovenous fistula may result in myocardial ischemia, infective endocarditis, severe systemic to pulmonary shunt, heart failure with high cardiac output, and fistula rupture [ 8 ].…”
Section: Discussionmentioning
confidence: 99%
“…This approach is particularly intriguing when disease is diffuse in the coronary artery and thus suboptimal for receiving a bypass graft. The feasibility of using coronary veins for myocardial revascularization was first reported in animal experiments and eventually in humans in the 1970s and has been reviewed [5, 7–14]. Limitations of the procedure included residual shunt flow and fibrous proliferation at the anastamosis and elsewhere in the native vein.…”
Section: Discussionmentioning
confidence: 99%